Clinical Trial Update: GARDASIL Reexamination Study (V501-059)

View source ↗

Summary

This document reports that the GARDASIL reexamination study V501-059 sponsored by Merck Sharp & Dohme LLC has completed, with results posted on March 27, 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Papillomavirus (HPV) Infection | Status: COMPLETED | Results posted: 2014-03-27